Related Experiment Video
Updated: Apr 11, 2026

A Multimodal Imaging- and Stimulation-based Method of Evaluating Connectivity-related Brain Excitability in Patients with Epilepsy
Published on: November 13, 2016
Epilepsy, Intellectual and Developmental Disabilities, and Contraception in U.S. Medicaid Claims Data
Laura Kirkpatrick1, Elizabeth I Harrison, Abrar O Al-Faraj
1Departments of Pediatrics, Neurology, General Internal Medicine, Neurobiology, and Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; the Department of Neurology, University of Virginia School of Medicine, Charlottesville, Virginia; the Department of Neurology, Boston Medical Center / Boston University Chobanian and Avedisian School of Medicine, and the Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts; the Department of Obstetrics & Gynecology, University of Rochester Medical Center, Rochester, New York; the Ayer Neuroscience Institute Comprehensive Epilepsy Center, Hartford HealthCare, Hartford, Connecticut; the Department of Neurology, University of Michigan, Ann Arbor, Michigan; and the Department of Pharmacy, Cleveland Clinic, Cleveland, Ohio.
Epilepsy slightly increases contraceptive prescription rates, while intellectual and developmental disabilities (IDD) decrease them among females with Medicaid. Co-occurring conditions show an intermediate effect on contraceptive provision.
Area of Science:
- Reproductive Health
- Neurology
- Public Health
Background:
- Contraceptive access is crucial for reproductive health.
- Epilepsy and intellectual and developmental disabilities (IDD) may influence healthcare decisions.
- Understanding these influences is vital for equitable care.
Purpose of the Study:
- To examine how epilepsy and IDD impact contraceptive provision in females with Medicaid insurance.
- To investigate the interaction between epilepsy and IDD on contraceptive access.
Main Methods:
- Utilized Medicaid claims data from 2016-2021 for females aged 12-51.
- Identified epilepsy and IDD using validated criteria and ICD-10 codes.
- Performed multivariable logistic regression to analyze contraceptive prescription patterns.
Main Results:
- Females with epilepsy were more likely to receive contraceptives (aOR 1.05).
- Females with IDD were less likely to receive contraceptives (aOR 0.57).
- Females with both conditions had intermediate likelihood (aOR 0.83), with significant differences in specific method prescriptions.
Conclusions:
- Epilepsy has a small but significant effect on contraceptive prescription.
- A significant interaction exists between epilepsy and IDD affecting contraceptive provision.
- Tailored approaches may be needed to ensure equitable contraceptive access for these populations.
More Related Videos
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Glutamate Antagonists
Intellectual Disability
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

